More than Dysbiosis: Imbalance in Humoral and Neuronal Bidirectional Crosstalk Between Gut and Brain in Alzheimer’s Disease
Open Access
- 29 December 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 369
Abstract
The intestinal microbiota, a diverse community of microorganisms residing in the human gut, recently attracted considerable attention as a contributing factor to various neurological disorders, including Alzheimer’s Disease (AD). Within the established framework of the gut–brain axis (GBA) concept, it is commonly suggested that dysbiosis, through microbial metabolites entering the brain, affect the cognitive functions in patients with AD. However, evidence for such a role of dysbiosis remains largely associative, and the complexity of the communication channels between the gut and the brain is not fully understood. Moreover, the new players of the GBA are emerging and the AD concept is constantly evolving. The objective of this narrative review is to synthesize the current evidence on the humoral, endocrine, immune, and neural communication mechanisms linking the gut and brain in AD and highlight newly discovered GBA messengers such as microRNAs, extracellular vesicles, T-cells, and the intestinal hormones, including emerging neuroprotective role for glucagon-like peptide-1 (GLP-1). Based on this knowledge, we aimed to develop a conceptual understanding of the GBA function in health and AD. We specify that, in AD, the GBA goes beyond a disrupted microbiome, but operates in conjunction with impaired intestinal secretion, motility, barrier permeability, and neuroinflammatory signaling. These factors are associated with the dysfunction of the hypothalamic–pituitary axis, altered somatic and autonomic neuronal gut regulation, and abnormal, due to memory problems, behavioral aspects of food intake. Identifying the individual profile of key molecular and cellular players contributing to an unbalanced GBA should optimize existing approaches or propose new approaches for the complex therapy of AD.Keywords
Funding Information
- Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan (BR27198099)
This publication has 142 references indexed in Scilit:
- Fecal short‐chain fatty acids vary by sex and amyloid statusAlzheimer's & Dementia, 2025
- Gut‐derived bacterial vesicles carrying lipopolysaccharide promote microglia‐mediated synaptic pruningAlzheimer's & Dementia, 2025
- Lateral hypothalamic area high-frequency deep brain stimulation rescues memory decline in aged rat: behavioral, molecular, and electrophysiological studyPflügers Archiv - European Journal of Physiology, 2025
- The neuroprotective properties of GLP‐1R agonists correlate with their ability to cross the blood‐brain barrierAlzheimer's & Dementia, 2024
- MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASEAlzheimer's & Dementia, 2023
- The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairmentAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
- Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile AcidsMolecular Neurobiology, 2023
- Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial–Host Interactions Facilitate the Bacterial Pathogen Invading the BrainCellular and Molecular Neurobiology, 2018
- Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer DiseaseJAMA Neurology, 2018
- Neurotransmitters: The Critical Modulators Regulating Gut–Brain AxisJournal of Cellular Physiology, 2016